Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 86501-86550 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05271578
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
NA
Recruiting
40 participants
Started: Jun 7, 2022 · Completed: Aug 31, 2025
2 conditions
3 sponsors
1 location
NCT05153759
EMS Providers' Health Initiative Study
NA
Recruiting
40 participants
Started: Jun 7, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05129345
Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US
N/A
Recruiting
150 participants
Started: Jun 7, 2022 · Completed: Dec 31, 2026
4 conditions
1 sponsor
2 locations
NCT06158607
Pre-exposure Prophylaxis (PrEP) Adherence Intervention for Women with Substance Use Disorders
NA
Recruiting
60 participants
Started: Jun 7, 2022 · Completed: May 30, 2025
1 condition
1 sponsor
1 location
NCT06822855
Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma
N/A
Recruiting
755 participants
Started: Jun 7, 2022 · Completed: Dec 31, 2026
3 conditions
1 sponsor
12 locations
NCT05435781
Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency
PHASE4
Recruiting
250 participants
Started: Jun 7, 2022 · Completed: Mar 1, 2028
3 conditions
3 sponsors
3 locations
NCT05365581
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
PHASE1
Recruiting
398 participants
Started: Jun 7, 2022 · Completed: Jun 30, 2027
3 conditions
1 sponsor
43 locations
NCT05294172
KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
PHASE3
Active, not recruiting
295 participants
Started: Jun 7, 2022 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT05418478
The Effect of Education Given to Patients With Heart Failure on Self-care, Drug Compliance and Quality of Life.
NA
Active, not recruiting
80 participants
Started: Jun 7, 2022 · Completed: Sep 10, 2025
1 condition
1 sponsor
1 location
NCT05477589
Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML
PHASE3
Recruiting
170 participants
Started: Jun 7, 2022 · Completed: Dec 31, 2031
2 conditions
1 sponsor
17 locations
NCT05666141
The Effect of Pharyngeal Electrical Stimulation on Peripheral Biomechanical Aspects of Deglutition
NA
Recruiting
84 participants
Started: Jun 7, 2022 · Completed: Sep 30, 2025
2 conditions
2 sponsors
1 location
NCT05268003
A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia
PHASE2
Active, not recruiting
26 participants
Started: Jun 7, 2022 · Completed: Oct 5, 2026
2 conditions
1 sponsor
1 location
NCT03828201
Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB
PHASE2
Recruiting
220 participants
Started: Jun 7, 2022 · Completed: May 31, 2027
1 condition
11 sponsors
2 locations
NCT05304416
Clinical Markers of Dysphagia in Cardiac Surgical Patients
N/A
Active, not recruiting
347 participants
Started: Jun 7, 2022 · Completed: Dec 31, 2026
2 conditions
3 sponsors
2 locations
NCT05205109
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ATG 037 Monotherapy and Combination Therapy With Pembrolizumab in Patients With Advanced Solid Tumors
PHASE1
Recruiting
98 participants
Started: Jun 7, 2022 · Completed: Feb 28, 2028
1 condition
2 sponsors
7 locations
NCT05396833
Study of Tuvusertib (M1774) in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320)
PHASE1
Active, not recruiting
120 participants
Started: Jun 7, 2022 · Completed: Apr 3, 2026
1 condition
2 sponsors
22 locations
NCT05403710
Botulinum Toxin Therapy in Hidradenitis Suppurativa
N/A
Recruiting
20 participants
Started: Jun 7, 2022 · Completed: Apr 30, 2028
2 conditions
3 sponsors
1 location
NCT05422417
Dorsomedial Prefrontal Neuromodulation in Treatment-resistant Depression
NA
Recruiting
75 participants
Started: Jun 7, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05092516
Home-based Brain Stimulation Treatment for Post-acute Sequelae of COVID-19 (PASC)
NA
Active, not recruiting
40 participants
Started: Jun 7, 2022 · Completed: Sep 15, 2025
2 conditions
1 sponsor
1 location
NCT05387928
A Study of KL340399 in Patients With Advanced Solid Tumors
PHASE1
Recruiting
30 participants
Started: Jun 7, 2022 · Completed: May 31, 2025
1 condition
1 sponsor
1 location
NCT05204446
Behavioral Intervention for Celiac Disease
NA
Enrolling by invitation
96 participants
Started: Jun 7, 2022 · Completed: Oct 1, 2026
1 condition
2 sponsors
1 location
NCT05826158
18F-mFBG LAFOV PET/CT Compared to 123I-mIBG Scintigraphy SPECT/CT for Evaluation of Children With Neuroblastoma
NA
Recruiting
25 participants
Started: Jun 6, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05378308
NOACs Use in AF or VTE (SUNSHINE Registry)
N/A
Recruiting
5,000 participants
Started: Jun 6, 2022 · Completed: May 31, 2027
3 conditions
1 sponsor
1 location
NCT05143931
Avoid and Resist Strategies for Weight Management
NA
Recruiting
500 participants
Started: Jun 6, 2022 · Completed: Feb 9, 2027
2 conditions
6 sponsors
1 location
NCT05075759
Testing Counseling and Mobile Health Interventions to Improve Physical Activity and Diet Quality in Survivors of Childhood Cancer
NA
Active, not recruiting
374 participants
Started: Jun 6, 2022 · Completed: Dec 31, 2026
2 conditions
2 sponsors
2 locations
NCT05406531
The Effectiveness of Psychological Interventions in Psycho-neuroendocrine-immune Network in Breast Cancer Survivors
NA
Recruiting
440 participants
Started: Jun 6, 2022 · Completed: Jun 30, 2025
4 conditions
2 sponsors
1 location
NCT06970015
Demographics, Diagnosis, Management, and Outcomes of Non-occlusive Mesenteric Ischemia.
N/A
Active, not recruiting
566 participants
Started: Jun 6, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05588284
Preservation of Venous Valvular Function After PMT for Acute DVT
NA
Enrolling by invitation
100 participants
Started: Jun 6, 2022 · Completed: Jun 6, 2025
1 condition
2 sponsors
7 locations
NCT05175105
A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Not Regularly Transfused, Followed by a 5-Year Extension Period
PHASE3
Active, not recruiting
30 participants
Started: Jun 6, 2022 · Completed: Jan 31, 2030
2 conditions
1 sponsor
19 locations
NCT05394740
Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy
PHASE1/PHASE2
Active, not recruiting
30 participants
Started: Jun 6, 2022 · Completed: Nov 30, 2025
3 conditions
2 sponsors
1 location
NCT05417100
Understanding How Methadone Treatment During Surgery Affects Pain Levels and the Need for Pain Medications After Surgery
PHASE3
Active, not recruiting
17 participants
Started: Jun 6, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05353478
Reducing Opioid Prescription After Kidney Stone Removal Surgery
N/A
Active, not recruiting
80 participants
Started: Jun 6, 2022 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT06445660
The Feasibility of a Radiological Score Based on CT Signs for Recognizing Salvageable Bowel in Acute Mesenteric Ischemia
N/A
Recruiting
200 participants
Started: Jun 6, 2022 · Completed: May 31, 2025
1 condition
1 sponsor
1 location
NCT05018117
Effects of Nicotine and Attention on Frequency Tuning in Auditory Cortex
EARLY_PHASE1
Recruiting
48 participants
Started: Jun 6, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04822636
Family Mental Health Family Navigator Project (FMHN)
NA
Recruiting
150 participants
Started: Jun 6, 2022 · Completed: Apr 1, 2026
1 condition
2 sponsors
1 location
NCT05407792
Efficacy and Safety of Long-term Oral Staphylococcus Albicans Tablets in Patients With Bronchiectasis
NA
Recruiting
134 participants
Started: Jun 6, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05413083
Evaluation of Cardiac Function in Acutely Decompensated Cirrhosis
N/A
Active, not recruiting
70 participants
Started: Jun 6, 2022 · Completed: Oct 31, 2024
3 conditions
1 sponsor
1 location
NCT05659017
Candidate Gene for Hyperferritinemia
N/A
Recruiting
100 participants
Started: Jun 6, 2022 · Completed: Sep 30, 2024
1 condition
1 sponsor
1 location
NCT05320406
RElugolix VErsus LeUprolide Cardiac Trial
PHASE2
Active, not recruiting
94 participants
Started: Jun 6, 2022 · Completed: Dec 30, 2025
11 conditions
3 sponsors
4 locations
NCT05205200
Immune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA)-BCTOP-L-M02
PHASE2
Recruiting
338 participants
Started: Jun 6, 2022 · Completed: Aug 1, 2026
2 conditions
13 sponsors
1 location
NCT05221970
Effectiveness and Suitability of the Online Mobile Application for the Mental and Physical Health of Cancer Patients
NA
Recruiting
600 participants
Started: Jun 6, 2022 · Completed: Oct 31, 2023
1 condition
2 sponsors
1 location
NCT05510817
Multiparametric Assessment to Investigate Prognostic Factors for Disease Evolution a nd Evolutionary Patterns of Cognitive Status in RRMS
NA
Recruiting
50 participants
Started: Jun 6, 2022 · Completed: Jun 6, 2026
1 condition
2 sponsors
1 location
NCT06760936
Pixantrone as Bridging Therapy to Allogenic Transplant or CAR-T Cell Therapy in DLBCL Patients
N/A
Active, not recruiting
15 participants
Started: Jun 6, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05700162
The Effect of Showing Photographs, Videos and Live Images of Their Babies to Mothers During Milking
NA
Enrolling by invitation
150 participants
Started: Jun 6, 2022 · Completed: Aug 8, 2024
3 conditions
1 sponsor
1 location
NCT05343013
TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy
PHASE2
Recruiting
25 participants
Started: Jun 6, 2022 · Completed: May 15, 2027
1 condition
2 sponsors
1 location
NCT04733534
An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer
PHASE2
Active, not recruiting
110 participants
Started: Jun 6, 2022 · Completed: Dec 31, 2027
2 conditions
3 sponsors
1 location
NCT04520217
Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects
PHASE1
Recruiting
40 participants
Started: Jun 6, 2022 · Completed: Dec 1, 2026
2 conditions
1 sponsor
1 location
NCT05320198
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
PHASE1/PHASE2
Recruiting
150 participants
Started: Jun 6, 2022 · Completed: Sep 30, 2026
7 conditions
1 sponsor
15 locations
NCT06275802
The Effect of Nutrition Education Interventions for Adolescents
NA
Recruiting
1,000 participants
Started: Jun 6, 2022 · Completed: Jun 30, 2024
5 conditions
1 sponsor
1 location
NCT05621720
Adopting a Health-social Partnership Program to Promote Health and Self-care Management Among Older Adults in the Community
NA
Recruiting
788 participants
Started: Jun 6, 2022 · Completed: Apr 30, 2025
1 condition
1 sponsor
1 location
Previous
1
More pages
1728
1729
1730
1731
1732
1733
1734
More pages
2369
Next